In CNS tumors, Kanno et al. have shown that the presence of somatic mutation in the VHL gene and loss of heterozygosity on chromosome 3p are detectable in tumors, astrocytomas, oligoastrocytoma, and anaplastic astrocytoma [80]. This evidence concerns the gene VHL and central nervous system neoplasm.